Of these 56 drugs, the majority of their targeted pathways were associated with tumour proliferation, such as cell cycle (seven drugs), DNA replication (seven drugs), mitosis (seven drugs), P53 pathway (two drugs) and PI3K/MTOR signalling (four drugs). This evidence concerns the gene MTOR and neoplasm.